These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 26099215)

  • 1. Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial.
    Fehlings MG; Nakashima H; Nagoshi N; Chow DS; Grossman RG; Kopjar B
    Spinal Cord; 2016 Jan; 54(1):8-15. PubMed ID: 26099215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Riluzole in Spinal Cord Injury Study (RISCIS)-Pharmacokinetic (PK) Sub-Study: An Analysis of Pharmacokinetics, Pharmacodynamics, and Impact on Axonal Degradation of Riluzole in Patients With Traumatic Cervical Spinal Cord Injury Enrolled in the RISCIS Phase III Randomized Controlled Trial.
    Chow DS; Nguyen A; Park J; Wu L; Toups EG; Harrop JS; Guest JD; Schmitt KM; Aarabi B; Fehlings MG; Boakye M; Grossman RG
    J Neurotrauma; 2023 Sep; 40(17-18):1889-1906. PubMed ID: 37130044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Riluzole in Acute Spinal Cord Injury Study (RISCIS): A Multi-Center, Randomized, Placebo-Controlled, Double-Blinded Trial.
    Fehlings MG; Moghaddamjou A; Harrop JS; Stanford R; Ball J; Aarabi B; Freeman BJC; Arnold PM; Guest JD; Kurpad SN; Schuster JM; Nassr A; Schmitt KM; Wilson JR; Brodke DS; Ahmad FU; Yee A; Ray WZ; Brooks NP; Wilson J; Chow DS; Toups EG; Kopjar B
    J Neurotrauma; 2023 Sep; 40(17-18):1878-1888. PubMed ID: 37279301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Riluzole as a neuroprotective drug for spinal cord injury: from bench to bedside.
    Nagoshi N; Nakashima H; Fehlings MG
    Molecules; 2015 Apr; 20(5):7775-89. PubMed ID: 25939067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Riluzole for the treatment of acute traumatic spinal cord injury: rationale for and design of the NACTN Phase I clinical trial.
    Fehlings MG; Wilson JR; Frankowski RF; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Harkema SJ; Guest JD; Tator CH; Burau KD; Johnson MW; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):151-6. PubMed ID: 22985381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole for acute traumatic spinal cord injury: a promising neuroprotective treatment strategy.
    Wilson JR; Fehlings MG
    World Neurosurg; 2014; 81(5-6):825-9. PubMed ID: 23295632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial.
    Ludolph AC; Schuster J; Dorst J; Dupuis L; Dreyhaupt J; Weishaupt JH; Kassubek J; Weiland U; Petri S; Meyer T; Grosskreutz J; Schrank B; Boentert M; Emmer A; Hermann A; Zeller D; Prudlo J; Winkler AS; Grehl T; Heneka MT; Wollebæk Johannesen S; Göricke B;
    Lancet Neurol; 2018 Aug; 17(8):681-688. PubMed ID: 29934198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of riluzole in the treatment of spinal cord injury: a systematic review of the literature.
    Srinivas S; Wali AR; Pham MH
    Neurosurg Focus; 2019 Mar; 46(3):E6. PubMed ID: 30835675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole promotes motor and respiratory recovery associated with enhanced neuronal survival and function following high cervical spinal hemisection.
    Satkunendrarajah K; Nassiri F; Karadimas SK; Lip A; Yao G; Fehlings MG
    Exp Neurol; 2016 Feb; 276():59-71. PubMed ID: 26394202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of a phase II placebo-controlled randomized trial of minocycline in acute spinal cord injury.
    Casha S; Zygun D; McGowan MD; Bains I; Yong VW; Hurlbert RJ
    Brain; 2012 Apr; 135(Pt 4):1224-36. PubMed ID: 22505632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of riluzole in acute spinal cord injury.
    Chow DS; Teng Y; Toups EG; Aarabi B; Harrop JS; Shaffrey CI; Johnson MM; Boakye M; Frankowski RF; Fehlings MG; Grossman RG
    J Neurosurg Spine; 2012 Sep; 17(1 Suppl):129-40. PubMed ID: 22985379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Impact of Acute Spinal Cord Injury on Clinical Pharmacokinetics of Riluzole, a Potential Neuroprotective Agent.
    Nguyen A; Chow DS; Wu L; Teng YA; Sarkar M; Toups EG; Harrop JS; Schmitt KM; Johnson MM; Guest JD; Aarabi B; Shaffrey CI; Boakye M; Frankowski RF; Fehlings MG; Grossman RG
    J Clin Pharmacol; 2021 Sep; 61(9):1232-1242. PubMed ID: 33908635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, multicenter, phase I matched-comparison group trial of safety, pharmacokinetics, and preliminary efficacy of riluzole in patients with traumatic spinal cord injury.
    Grossman RG; Fehlings MG; Frankowski RF; Burau KD; Chow DS; Tator C; Teng A; Toups EG; Harrop JS; Aarabi B; Shaffrey CI; Johnson MM; Harkema SJ; Boakye M; Guest JD; Wilson JR
    J Neurotrauma; 2014 Feb; 31(3):239-55. PubMed ID: 23859435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of riluzole and dantrolene improves significant recovery after acute spinal cord injury in rats.
    Martins BC; Torres BBJ; de Oliveira KM; Lavor MS; Osório CM; Fukushima FB; Rosado IR; de Melo EG
    Spine J; 2018 Mar; 18(3):532-539. PubMed ID: 29155254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of riluzole in patients undergoing decompressive surgery for degenerative cervical myelopathy (CSM-Protect): a multicentre, double-blind, placebo-controlled, randomised, phase 3 trial.
    Fehlings MG; Badhiwala JH; Ahn H; Farhadi HF; Shaffrey CI; Nassr A; Mummaneni P; Arnold PM; Jacobs WB; Riew KD; Kelly M; Brodke DS; Vaccaro AR; Hilibrand AS; Wilson J; Harrop JS; Yoon ST; Kim KD; Fourney DR; Santaguida C; Massicotte EM; Kopjar B
    Lancet Neurol; 2021 Feb; 20(2):98-106. PubMed ID: 33357512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Riluzole for treating spasticity in patients with chronic traumatic spinal cord injury: Study protocol in the phase ib/iib adaptive multicenter randomized controlled RILUSCI trial.
    Cotinat M; Boquet I; Ursino M; Brocard C; Jouve E; Alberti C; Bensoussan L; Viton JM; Brocard F; Blin O
    PLoS One; 2023; 18(1):e0276892. PubMed ID: 36662869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury.
    Koda M; Hanaoka H; Sato T; Fujii Y; Hanawa M; Takahashi S; Furuya T; Ijima Y; Saito J; Kitamura M; Ohtori S; Matsumoto Y; Abe T; Watanabe K; Hirano T; Ohashi M; Shoji H; Mizouchi T; Takahashi I; Kawahara N; Kawaguchi M; Orita Y; Sasamoto T; Yoshioka M; Fujii M; Yonezawa K; Soma D; Taneichi H; Takeuchi D; Inami S; Moridaira H; Ueda H; Asano F; Shibao Y; Aita I; Takeuchi Y; Mimura M; Shimbo J; Someya Y; Ikenoue S; Sameda H; Takase K; Ikeda Y; Nakajima F; Hashimoto M; Ozawa T; Hasue F; Fujiyoshi T; Kamiya K; Watanabe M; Katoh H; Matsuyama Y; Yamamoto Y; Togawa D; Hasegawa T; Kobayashi S; Yoshida G; Oe S; Banno T; Arima H; Akeda K; Kawamoto E; Imai H; Sakakibara T; Sudo A; Ito Y; Kikuchi T; Osaki S; Tanaka N; Nakanishi K; Kamei N; Kotaka S; Baba H; Okudaira T; Konishi H; Yamaguchi T; Ito K; Katayama Y; Matsumoto T; Matsumoto T; Idota M; Kanno H; Aizawa T; Hashimoto K; Eto T; Sugaya T; Matsuda M; Fushimi K; Nozawa S; Iwai C; Taguchi T; Kanchiku T; Suzuki H; Nishida N; Funaba M; Yamazaki M
    BMJ Open; 2018 May; 8(5):e019083. PubMed ID: 29730616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Riluzole in cerebellar ataxia: a randomized, double-blind, placebo-controlled pilot trial.
    Ristori G; Romano S; Visconti A; Cannoni S; Spadaro M; Frontali M; Pontieri FE; Vanacore N; Salvetti M
    Neurology; 2010 Mar; 74(10):839-45. PubMed ID: 20211908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riluzole decreases flexion withdrawal reflex but not voluntary ankle torque in human chronic spinal cord injury.
    Theiss RD; Hornby TG; Rymer WZ; Schmit BD
    J Neurophysiol; 2011 Jun; 105(6):2781-90. PubMed ID: 21430280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.